March 10, 2016.
The European Generic and Biosimilar Medicines Association (EGA) has changed its name to Medicines for Europe. In a press release issued today, Medicines for Europe President Jacek Glinka explained that the repositioning "reflects our industries’ purpose and strategic objectives ... [W]e have been through an incredible journey responding to the changes that have taken place in the pharmaceutical industry and European healthcare environment. I invite stakeholders and policy-makers to engage with us to deliver access to high quality medicines for all European patients.” http://www.medicinesforeurope.com/
Can Data and AI Deliver Whole-Person Health?
July 9th 2024Executives in the life sciences and medical device industries see promise in artificial intelligence (AI) and medical technologies, but must also navigate the changing healthcare ecosystem, varied stakeholder needs, and the impact of AI on market access and commercialization strategies.